跳至主要内容
临床试验/NCT04509258
NCT04509258Unknown4 期

Comparative Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Acute Aluminium Phosphide Poisoning: A Clinical Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2020年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
100
试验地点
1
主要终点
mortality rate reduction

研究概览

简要总结

Aluminium Phosphide is a pesticide used in developing countries to prevent rodents and pests from spoiling the harvested grains. it is presented as tablets which can be administered accidently to humans or for committing suicide. this pesticide is fatal even in small concentration as mortality rate can reach 75- 100% of cases. in this study researchers tried to add some supplements to the routine treatment to improve and decrease the fatality rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult patients with history of acute intoxication with AlP presented to the Poison Control Center of Ain-Shams University hospitals during the period of the study

排除标准

  • Patients less than 18
  • Patients presented with delay time exceeding 12 hours after acute intoxication.
  • Patients with history of cardiac, renal or hepatic diseases.
  • Patients who show hypersensitivity to NAC, ALCAR or paraffin oil.

研究组 & 干预措施

control group

Placebo Comparator

this group will have the standard and routine therapy of treatment of acute Aluminium Phosphide poisoning immediately after admission according to PCCA guidelines

干预措施: Sodium Bicarbonate Powder and ondansetron (Drug)

N- acetyl cysteine grouo

Active Comparator

N-acetyl cysteine will be given at dose of 300mg/kg/d IV in the first day then 150 mg/kg/d IV in addition to standard of care according to PCCA guidelines

干预措施: N-acetyl cysteine (Drug)

N- acetyl cysteine grouo

Active Comparator

N-acetyl cysteine will be given at dose of 300mg/kg/d IV in the first day then 150 mg/kg/d IV in addition to standard of care according to PCCA guidelines

干预措施: Sodium Bicarbonate Powder and ondansetron (Drug)

Acetyl L-carnitine group

Active Comparator

Acetyl L-carnitine will be given at dose of 50 mg/kg IV once to be followed by additional doses of 15 mg/kg IV q4hr infused over 30 min. standard of care according to PCCA guidelines will also be provided

干预措施: acetyl L-carnitine (Dietary Supplement)

Acetyl L-carnitine group

Active Comparator

Acetyl L-carnitine will be given at dose of 50 mg/kg IV once to be followed by additional doses of 15 mg/kg IV q4hr infused over 30 min. standard of care according to PCCA guidelines will also be provided

干预措施: Sodium Bicarbonate Powder and ondansetron (Drug)

Medicated paraffin oil group

Active Comparator

Gastric decontamination with sodium bicarbonate (NaHCO3; 44 mEq, orally) and medicated paraffin oil (200 mL) will be administered in addition to standard of care according to PCCA guidelines

干预措施: medicated paraffin oil (Drug)

Medicated paraffin oil group

Active Comparator

Gastric decontamination with sodium bicarbonate (NaHCO3; 44 mEq, orally) and medicated paraffin oil (200 mL) will be administered in addition to standard of care according to PCCA guidelines

干预措施: Sodium Bicarbonate Powder and ondansetron (Drug)

结局指标

主要结局

mortality rate reduction

时间窗: 1 year

the primary end point is to lower the mortality rate for patients poisoned with aluminium phosphide pellets

organ damage reduction

时间窗: 1 year

another primary end point is to reduce organ damage and injury for survivors

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dalia K. Zaafar

lecturer of pharmacology

Cairo University

研究点 (1)

Loading locations...

相似试验